HR 3677
106th Congress
House
Health
Access to health care
Clinical trials
Drug approvals
Drugs
Informed consent (Medical law)
Law
Patients' rights
Pharmaceutical research
Science, Technology, Communications
Thomas Navarro FDA Patient Rights Act
Introduced: February 16, 2000
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 15, 2000
Sponsor introductory remarks on measure. (CR E2230-2231)
Feb 23, 2000
Referred to the Subcommittee on Health and Environment.
Feb 16, 2000
Referred to the House Committee on Commerce.
Feb 16, 2000
Introduced in House
Plain-English summary
Thomas Navarro FDA Patient Rights Act - Amends the Public Health Service Act to prohibit the Secretary of Health and Human Services from placing a clinical hold on an investigation of a drug on the basis that the Secretary has determined that: (1) there is another drug (including another investigational drug) that is or may be a safe and effective therapy for the disease or condition involved; or (2) there is a comparable or satisfactory alternative therapy available for a patient who is receiving or will receive the drug as a clinical subject in the investigation, subject to exception.
What's happening now
Sponsor introductory remarks on measure. (CR E2230-2231)
Committees of jurisdiction
2